Efficacy and Safety of HA35 Gel for Post-Dental Gingival Pain and Swelling

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorNakhia Impex LLC

About this trial

This is a prospective, single-arm, open-label, pilot clinical study to evaluate the efficacy and safety of 10% high-concentration 35 kDa hyaluronan (HA35) gel delivered via gel-soaked cotton balls in patients with gingival pain and swelling after dental procedures. Eligible participants will gently chew and retain the gel-soaked cotton balls on the affected area for 30 minutes. The primary objectives are to assess changes in gingival pain and swelling at 1, 30, and 60 minutes after application. Safety and local oral tolerability will be evaluated throughout the observation period. This is a minimal-risk, non-pharmacological, non-invasive intervention.

Eligibility criteria

Qualifiers

Age 18-65 years, male or female

Experienced gingival pain and swelling within 12 hours after dental procedures

Baseline gingival pain NRS score ≥2

Able to independently complete pain and swelling assessments

Disqualifiers

Severe periodontitis, uncontrolled diabetes, or immune dysfunction

Long-term use of analgesics or anti-inflammatory drugs

Known hypersensitivity to hyaluronan or gel components

Oral infection, ulceration, or severe mucosal injury at the application site

Trial design

Treatments tested in this trial

  • 10% High-Concentration 35 kDa Hyaluronan (HA35) Oral Topical Gel

Treatment groups

30 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators